CollPlant Biotechnologies (CLGN) Interest Coverage Ratio (QoQ) (2018 - 2021)
CollPlant Biotechnologies (CLGN) Interest Coverage Ratio (QoQ) (2018 - 2021) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -128.10% |
| Sep 30, 2021 | -99.90% |
| Jun 30, 2021 | 172.56% |
| Mar 31, 2021 | -75,552.68% |
| Dec 31, 2020 | -1,045,213.08% |
| Sep 30, 2020 | -100.00% |
| Jun 30, 2020 | 124.14% |
| Mar 31, 2020 | 22,440.26% |
| Dec 31, 2019 | -252.10% |
| Sep 30, 2019 | 100.43% |
| Jun 30, 2019 | -11,086.44% |
| Mar 31, 2019 | -785.54% |
| Dec 31, 2018 | -99.85% |
| Sep 30, 2018 | 4,434.56% |
| Jun 30, 2018 | -68.19% |
| Mar 31, 2018 | 10,947.49% |